Erythrocyte-mimicking paclitaxel nanoparticles for improving biodistributions of hydrophobic drugs to enhance antitumor efficacy
Recent decades have witnessed several nanocrystal-based hydrophobic drug formulations because of their excellent performance in improving drug loading and controlling drug release as mediate drug forms in tablets or capsules. However, the intravenous administration of drug nanocrystals was usually h...
Main Authors: | Zheng Zhai, Pengcheng Xu, Jun Yao, Ridong Li, Lidong Gong, Yuxin Yin, Zhiqiang Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2020.1731862 |
Similar Items
-
Using Mesoporous Silica-Based Dual Biomimetic Nano-Erythrocytes for an Improved Antitumor Effect
by: Ziyue Xi, et al.
Published: (2023-12-01) -
Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein
by: Chen H, et al.
Published: (2018-09-01) -
Erythrocytes Nanoparticle Delivery: A Boon for Targeting Tumor
by: Adnan Rehmatullah Siddique, et al.
Published: (2024-03-01) -
Erythrocyte membrane with CLIPPKF as biomimetic nanodecoy traps merozoites and attaches to infected red blood cells to prevent Plasmodium infection
by: Zhouqing He, et al.
Published: (2023-01-01) -
Harnessing PD-1 cell membrane-coated paclitaxel dimer nanoparticles for potentiated chemoimmunotherapy
by: Nannan Hu, et al.
Published: (2024-05-01)